Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2 Study of High Risk Prostatae Cancer Treated With Dose-escalated Simultaneous Integrated Boost to Prostate and Lymph Node GTV

NCT01962324 is registered in ClinicalTrials.gov with Umeå University as lead sponsor.

NCT NCT01962324
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01962324 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2 Study of High Risk Prostatae Cancer Treated With Dose-escalated Simultaneous Integrated Boost to Prostate and Lymph Node GTV
Lead sponsor
Umeå University
Phase
Not applicable
Overall status
Completed
Start date
March 31, 2015
Completion date
May 9, 2023
Enrollment
85 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lymphatic metastasis, prostatic neoplasms